Development of an enzymatic screening method for d-aspartate-producing lactic acid bacteria.

Enzymatic screening Lactic acid bacteria d-aspartate d-aspartate oxidase

Journal

Enzyme and microbial technology
ISSN: 1879-0909
Titre abrégé: Enzyme Microb Technol
Pays: United States
ID NLM: 8003761

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 01 12 2020
revised: 25 05 2021
accepted: 28 05 2021
entrez: 27 7 2021
pubmed: 28 7 2021
medline: 19 8 2021
Statut: ppublish

Résumé

d-Aspartate (d-Asp) is an important intermediate for synthetic penicillin and an endogenous amino acid that plays important roles in the endocrine and nervous systems in animals including humans. Lactic acid bacteria (LABs) have been used as probiotics in humans, and some LAB species produce d-Asp as a component of cell wall peptidoglycan. LAB strains with greater d-Asp production would therefore be valuable for industrial d-Asp production. In this study, we developed an enzymatic screening method for d-Asp-producing LABs and isolated a strain with high d-Asp production. The d-Asp concentration in the culture medium was colorimetrically estimated up to 4 mM using d-aspartate oxidase (ChDDO) from the yeast Cryptococcus humicola strain UJ1 coupled with horseradish peroxidase, although a more accurate determination required correction because of interference by the medium component Mn

Identifiants

pubmed: 34311880
pii: S0141-0229(21)00093-4
doi: 10.1016/j.enzmictec.2021.109835
pii:
doi:

Substances chimiques

Amino Acids 0
Aspartic Acid 30KYC7MIAI
D-Aspartic Acid 4SR0Q8YD1X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109835

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Kengo Kajitani (K)

Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.

Takumi Ishikawa (T)

Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.

Kimihiko Shibata (K)

Department of Applied Chemistry and Biochemistry, National Institute of Technology, Fukushima College, Iwaki, Fukushima, 970-8034, Japan.

Tomoaki Kouya (T)

Department of Materials Chemistry and Bioengineering, National Institute of Technology, Oyama College, Tochigi, 323-0806, Japan.

Yoshio Kera (Y)

Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.

Shouji Takahashi (S)

Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan. Electronic address: shoutaka@vos.nagaokaut.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH